MLSS: Q3 2025 saw stable revenue, reduced expenses, and improved margins amid ongoing transformation
閱讀少於1分鐘
Stable Q3 2025 revenue was supported by international dental and medical growth, while operating expenses fell by over $500K year-over-year. Gross margin remained strong at 70%, and operational transformation is expected to drive future margin improvement and value creation.
Original document: Milestone Scientific, Inc. [MLSS] SEC 8-K Current Report — Nov. 14 2025
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr